Early trial data shows a drug developed using artificial intelligence can slow the growth of cancer in clinical trials.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
According to scientists from US biotechnology company Berg, data from 85 patients showed signs the approach could kill tumors. The trial was designed to test only for toxicity, but in one patient the tumor shrank by a 25%.